Mednet Logo
HomeRadiation OncologyQuestion

Are there situations in which you would definitely recommend radiation in an elderly patient with ER+, early stage breast cancer?

5
6 Answers
Mednet Member
Mednet Member
Radiation Oncology · Brown University

I always have a little trepidation in answering questions whereby I would “definitely” recommend any therapeutic path as clinical decision making needs to be a bit more nuanced. Every situation requires a careful weighing of multiple inputs including clinical trial data and patient-specific fact...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

Dr Wazer has written a thoughtful scholarly answer to this question with which I agree, but I would emphasize his concluding sentences. Too little attention has been paid to the issue of RT alone vs hormonal rx alone and the relative toxicities of each. Particularly with the use of AI's, compliance ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Washington University School of Medicine

I wholeheartedly agree with @Dr. First Last and @Dr. First Last. Their answers do take us a few steps away from the original question to the larger issue of what if any adjuvant therapy is needed for women with small breast cancers.

It is disappointing that the option of adjuvant radiation alone was ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

One additional factor is patient willingness to proceed with endocrine therapy and be compliant on treatment. Otherwise, I use high grade, nodal positivity, multicentricity

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

At I present would offer RT for high grade (based on prime2) or node positive disease (not included in prime or CALGB)

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Cancer Care Centers of Brevard

15-20 year+ life expectancy.

The Calgb trial did in fact show a difference in IBTR rates, it's just that that difference was not felt to be clinically significant at 10 years of follow up. That rate of recurrence is a function of time and will increase with further follow up.

If a 70-75 year yo fem...

Register or Sign In to see full answer